Interleukin Genetics' IPO

Interleukin Genetics raised a round of funding on November 27, 1997. Investors include Public.

Interleukin Genetics (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products enable individuals to prevent certain chronic conditi…

Articles about Interleukin Genetics' IPO: